NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene

Table 1 Demographic, clinical, and pathological characteristics of the patients in microarray analyses

Patient	Diagnosis age	Gleason score	WHO grade	T*	N ^†	M ^‡	Primary PSA^§
015-001**	53 y 7 m	n.a.	II	T1c	Nx	M0	n.a.
043-001**	50 y 9 m	6	II	T2	Nx	M0	3.8
232-001**	70 y 7 m	7	II	T1c	Nx	M0	6.2
232-002**	75 y 5 m	n.a.	n.a.	T1a	Nx	M0	1.3
248-006**	59 y 3 m	6	I	T1c	Nx	M0	2.9
311-003**	60 y 4 m	6	II	T2	Nx	M0	21.9
001-002	71 y 8 m	n.a.	II	T3	Nx	M0	n.a.
292-010	47 y 11 m	6	II	T2	Nx	Mx	5.2
408-002	67 y 5 m	7	II	T1c	Nx	Mx	5.5
236-006	75 y 11 m	n.a.	n.a.	T3	Nx	Mx	85
402-003	67 y 3 m	6	I	T2	Nx	M0	13
402-001	67 y 11 m	7	II	T1c	Nx	M0	15
413-003	55 y 3 m	7	II	T1c	Nx	M0	6.4
362-001	50 y 7 m	6	I	T1b	Nx	M0	6.9
362-002	49 y 4 m	6	I	T1c	Nx	Mx	41.9

ISSN: 1471-2407